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Abstract: The discovery of increasing numbers of genes with overlapping
sequences highlights the problem of expression in the context of constraining
regulatory elements from more than one gene. This study identifies
regulatory sequences encompassed within two genes that overlap in an
antisense orientation at their 3′ ends. The genes encode the α-thyroid
hormone receptor gene (TRα or NR1A1) and Rev-erbα (NR1D1). In mammals
TRα pre-mRNAs are alternatively spliced to yield mRNAs encoding functionally
antagonistic proteins: TRα1, an authentic thyroid hormone receptor; and
TRα2, a non-hormone-binding variant that acts as a repressor. TRα2-specific
splicing requires two regulatory elements that overlap with Rev-erbα
sequences. Functional mapping of these elements reveals minimal splicing
enhancer elements that have evolved within the constraints of the
overlapping Rev-erbα sequence. These results provide insight into the
evolution of regulatory elements within the context of bidirectional coding
sequences. They also demonstrate the ability of the genetic code to
accommodate multiple layers of information within a given sequence, an
important property of the code recently suggested on theoretical grounds.
Keywords: alternative splicing, exonic splicing enhancer, intronic splicing
enhancer, antisense RNA, genetic code, exon evolution, nuclear receptor
proteins

Introduction
A single genomic locus can give rise to more than one distinct
protein product through alternative RNA splicing, alternative promoters
and differential 3′ end processing.1 Because transcription can occur on
either strand of the DNA, a single genomic locus can also produce
RNAs from the opposite DNA strand, resulting in potential formation of
complementary transcripts termed cis-encoded natural antisense
transcripts (cis-NATs or cis-antisense RNAs).2, 3 Regulatory
mechanisms associated with antisense transcription and alternative
splicing are at present poorly understood. However, it is clear that the
combination of alternative splicing and overlapping transcription
greatly increases the complexity and information density of the human
transcriptome.4–8 It has been estimated that upwards of 95% of
protein-coding transcription units give rise to alternatively spliced
mRNAs7, 9–11 and more than 70% of transcription units in the human
genome are transcribed in both directions.5, 12, 13
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In this study we examine requirements for alternative
processing within the mammalian α-thyroid hormone (T3) receptor
gene (TRα). This gene yields two alternatively spliced mRNAs that
encode two functionally antagonistic proteins, TRα1 and TRα2.14 TRα1
(NR1A1a) is an authentic nuclear receptor that together with the
related receptors, TRβ1 (NR1A2a) and TRβ2 (NR1A2b), encoded by the
TRβ gene, mediates the cellular response to T3.15 Each of these
nuclear receptors has an N-terminal DNA-binding domain that
recognizes T3 response elements (TREs) and a C-terminal ligandbinding domain that binds T3 and activates T3-responsive genes. In
contrast, TRα2 (NR1A1b) is a non-hormone-binding variant that differs
from TRα1 in its C-terminal domain and neither binds T3 nor activates
transcription. TRα2 is thought to modulate the response to T3 by
dominant-negative interference with the hormone-responsive
isoforms.14, 16 Consistent with this hypothesis, expression of TRα2 is
developmentally regulated in many tissues, including brain, where it is
the predominant TRα isoform.14, 17, 18
The structure of TRα2 reflects its unique 3′ exon, which is
located downstream of the polyadenylation site for TRα1 mRNA. This
exon overlaps the 3′ exon of another mRNA on the opposite strand of
the chromosome that encodes a third nuclear receptor, Rev-erbα
(NR1D1).19, 20 Although long regarded as a ligandless orphan receptor,
Rev-erbα has recently been shown to bind heme specifically in its
canonical ligand-binding domain.21, 22 In the presence of this ligand,
the interaction of Rev-erbα with co-repressors is responsive to
physiological regulators such as nitric oxide. These results and the
well-documented role of Rev-erbα as a component of the mammalian
molecular clock demonstrate that Rev-erbα, like TRα1, serves as a
critical physiological regulator.21–24 The overlap between TRα2 and
Rev-erbα may have important consequences for the balance between
TRα1 and TRα2, as indicated by in vivo and in vitro analysis.25–28
Several recent studies have demonstrated that requirements for
splicing regulatory elements constrain the coding sequence of
alternatively spliced mRNAs.29–32 Since the overlap between the Reverbα and TRα genes includes a portion of the C-terminal coding
sequence of both genes, it seemed likely that requirements for coding
might represent an overriding constraint that restricts regulatory
elements for TRα2 splicing to sites outside of the overlap. Contrary to
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this expectation, experiments reported here define two splicing
enhancers, TR-ISE3 and ESX10, that are located within the overlap
between TRα2 and Rev-erbα where they flank the TRα2-specific 3′
splice site (ss). Most notably, ESX10 maps directly to the bidirectional
coding sequence (BCS) associated with the overlap between coding
sequences for both TRα2 and Rev-erbα. These results provide a
striking demonstration of the ability of the genetic code to
accommodate multiple layers of information and raise interesting
questions concerning the evolution of this gene overlap.33

Results
Sequence and structure of the TRα and Rev-erbα
overlap
As shown in Figure 1, TRα1 mRNA is formed by splicing exon 1
through exon 9 whereas TRα2 mRNA is formed by splicing the 5′ end
of exon 9 (exon 9A) to exon 10. Exon 10 overlaps the final exon of
Rev-erbα such that the 3′ end of Rev-erbα mRNA overlaps the 3′ss of
TRα2 mRNA and vice versa. Together the two transcription units
occupy 34 kb on rat chromosome 10 with a 1.1 kb overlap. The 263 bp
exon-exon overlap between TRα2 and Rev-erbα includes the 200 bp
BCS comprising 67 codons at the C-terminus of each protein that
share an in-phase overlap. Furthermore the poly(A) site of TRα2 mRNA
maps within 50 bp of the final 5′ ss of Rev-erbα mRNA, and that of
Rev-erbα mRNA maps between the poly(A) site of TRα1 and the 3′ss of
exon 10 imposing additional constraints on this region.
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Figure 1

Structure and processing of TRα2 mRNA. A. Schematic representation of

the structure of the TRα and Rev-erbα genes which overlap by 1.1 kb on rat
chromosome 10 (position 316154–338490; reference assembly RGSC v3.4). Boxes
represent exons which are numbered for TRα, pointed boxes are 3′ terminal exons and
horizontal lines are introns. The positions of three splicing enhancers including SEα2,
previously described 34, TR-ISE3 and ESX10, are represented by hatched ellipses.
Splicing of exons 9A and 10 in TRα2 mRNA is indicated by a dotted angled line. Dark
gray shading represents coding sequences, light gray shading untranslated regions.
The position of the minigenes cloned in pErbA is indicated by a bracket at top. Bold
letters (B,S, X) indicate endpoints of deletions. The TRα/Rev-erbα overlap region is
highlighted by shading. B. To-scale representation of the 1.4 kb region shaded in
Panel A. Splicing enhancers TR-ISE3 and ESX10 are indicated by hatched ellipses. C.
Segmented bar indicates regions defined by processing sites, base composition and
conservation. Segments are labeled as follows: pA is poly(A) site; Rev is Rev-erbα; Cn
and Gn denote C-rich and G-rich regions, respectively; BCS is bidirectional coding
sequence; and 3′ UTR is the 3′ untranslated region. Single letters above bar indicate
endpoints of deletions within minigenes. Numbers at bottom indicate sequence identity
between rat and human.

As a first step towards understanding constraints introduced by
the overlap between these genes we compared the genomic sequences
of six mammals (human, chimp, mouse, rat, dog and cow) across the
region including the overlap between TRα2 and Rev-erbα mRNAs and
the adjacent 3′ sequence of TRα1 mRNA (Supplementary data, Table
S1). Although sequences throughout the region where TRα1, TRα2 and
Rev-erbα mRNAs converge are highly conserved, local variations in
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sequence composition and conservation reflect diverse constraints.
Within the region highlighted in Figure 1C there are three areas of very
high conservation, illustrated here for the rat-human alignment. These
include a stretch of 200 bp at the 3′ end of exon 9 of TRα1 mRNA, 100
bp upstream of the 3′ss for exon 10 in TRα2 mRNA and 300 bp at the
5′ end of exon 10 (Table S1). Between the TRα1 poly(A) site and the
3′ exon of TRα2 70 bp of sequence antisense the Rev-erbα poly(A) site
are also highly conserved (96% identity). This region is flanked
upstream and downstream by C-rich and G-rich regions (Cn and Gn,
respectively; Figure 1C) that are less tightly conserved with numerous
runs of three or more consecutive C or G residues. These features
reflect multiple, overlapping requirements for transcription, processing
and translation on one or both strands.

The TRα2-specific 3′splice site is suboptimal
To understand functional constraints introduced by the overlap
with Rev-erbα and how they may relate to regulation of TRα
expression, we examined sequences directly involved in TRα2 splicing.
Many alternative splice sites are suboptimal in their match to
consensus sequences and their efficiency of splicing. For example, a
previous study showed that replacement of a single non-consensus
nucleotide at the 5′ss of TRα2 (+5C/G) greatly increases TRα2 splicing
28
. Since the 3′ss of exon 10 is also a poor match to the consensus
sequence, with AAG (vs. CAG) immediately preceding the splice site
(Figure 2A), the non-consensus adenosine was replaced with cytidine
(−3A/C) in a minigene construct, pErbAΔBS, that lacks the upstream
SEα2 enhancer required for efficient splicing.28, 34 This singlenucleotide substitution results in a substantial increase in splicing,
although it is less than that seen when the +5C/G mutation is
incorporated into the 5′ss of this construct (Figure 2B). These results
demonstrate that both 3′ss and 5′ss are suboptimal and contribute to
the regulation of TRα1/TRα2 mRNA levels. The lower splicing efficiency
of the 3′ss substitution may reflect other suboptimal features of this
site such as a non-consensus branch point (Hastings, unpublished
result).
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Figure 2

The TRα2-specific splice sites are suboptimal. A. Sequences of 5′ and 3′

splice site sequences and corresponding point mutations. B. RNase protection assays
of TRα2-splicing of wildtype and mutant ErbAΔBS pre-mRNAs in HEK293 transfected
cells. The control lane (C) shows cells transfected with vector plasmid express no
detectable endogenous TRα1 or TRα2 mRNA. Structure of the ErbAΔBS minigene is
shown at right with the position of the probe indicated by the bold line. Arrows labeled
“U” and “S” indicate bands corresponding to unspliced and spliced RNAs, respectively,
and % splicing is shown below each lane. Double bands in some lanes represent
partial protection of ends of RNase trimmed probes hybridized to unspliced RNA.
Results are representative of two independent experiments.

Sequences at the 3′ end of the regulated intron
enhance TRα2 mRNA splicing
Because suboptimal splice sites often are regulated by intronic
or exonic splicing enhancer elements (ISEs or ESEs), requirements for
sequences adjacent to the TRα2 3′ss in splicing regulation were
evaluated through a series of deletions upstream of the 3′ ss. Previous
studies showed that one such splicing enhancer element, SEα2, lies
within an 80 nt region directly downstream of the TRα1 coding
sequence.28, 34 Here, two series of deletions in the 3′ss region were
examined that differ in the presence or absence of the SEα2 splicing
enhancer34, one derived from pErbAΔXS and the other from pErbAΔBS
(Figure 3A). RNase protection assays show a dramatic stimulation of
TRα2 splicing in RNA from the ΔBD, ΔBE and ΔBP minigenes. These
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results demonstrate that sequences upstream of the polypyrimidine
also contribute to TRα2 splicing efficiency (Figure 3B). A parallel
increase was seen in splicing of transcripts ErbAΔXD, ErbAΔXE and
ErbAΔXP compared with that of the parent construct, ErbAΔXS (Figure
3B). As the difference in splicing observed with ErbAΔBE and ErbAΔBP
is small relative to that between ErbAΔBS and ErbAΔBD or ErbAΔBE
(with parallel results for the series ErbAΔXS through ErbAΔXP), we
conclude that the sequences between site “E” and “P” in ΔBE and ΔBP
contribute marginally to TRα2 splicing. Consequently, the ES fragment
(present in ΔBE and ΔXE but absent in ΔBS and ΔXS) includes an
intronic splicing enhancer which we designated TR-ISE3.

Figure 3

Intronic sequences adjacent to the TRα2 3′ss are required for efficient

splicing of TRα2 mRNA. A. Structure of ErbA minigene pre-mRNA is shown on top and
the structures of 9 deletion constructs within the final exon of TRα2 mRNA are shown
below. Splicing of ErbAΔBS and ErbAΔXS pre-mRNAs, has been described previously
28. Light shading of BX fragment indicates SEα2 enhancer, dark shading sequences
overlapping TR-ISE3. Endpoints of deletions are indicated by letters B, X, P, E, D,S
and by inverted triangles for deletions DS-20L and DS-20R shown in panel E. Speckled
shading indicates 300 nts of heterologous sequence in ErbAΔBS-H derived from
lambda phage. B. RNase protection assays showing splicing of deleted pre-mRNAs
expressed in HEK293 as in Fig. 2. Splicing of ΔBS series, lacking 5′ss proximal SEα2
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enhancer, and ΔXS series including the SEα2 enhancer is shown 34. % Splicing
(average of 3 experiments except for ErbA-H) and standard deviation (SD) is shown at
bottom of figure. C. RNase protection assays showing effect of deleting 20 nts from
either the 5′ end (-20L) and 3′ end (-20R) of the DS fragment present in ErbAΔBD as
indicated in Panel A (inverted triangles) and Panel E. % splicing and standard
deviation shown for 6–12 experiments. D. In vitro splicing of 32P-labeled transcripts
following 0, 45 and 90 min incubation with HeLa cell nuclear extract. % splicing is
representative of three experiments. E. Sequence of TR-ISE3 with downstream
endpoints of deletions indicated with (/) and labels. Runs of 3 or more G residues are
shown in bold. “U” and “S” indicate unspliced and spliced RNAs.

Interestingly, the effects of SEα2 and TR-ISE3 appear additive;
that is, the increase in splicing of transcripts in the series ErbAΔXS
through ErbAΔXP closely matches that observed with the series
ErbAΔBS through ErbAΔBP. When the percent splicing of ErbAΔBS is
subtracted from the percent splicing observed with ErbAΔBD, ErbAΔBE
and ErbAΔBP, the results are similar to those obtained by subtracting
the percent splicing of ErbAΔXS from that for ErbAΔXD, ErbAΔXE and
ErbAΔXP (e.g. 16%, 23% and 23% vs. 15%, 20% and 21%,
respectively, as shown in Figure 3B). The additive effects of SEα2 and
TR-ISE3 suggest that these two enhancers function independently of
one another.
Mapping of TR-ISE3 was confirmed by additional experiments.
Deletion of 20 nts from either end of the DS fragment in ErbαΔBD (DS20L or DS-20R) containing the TR-ISE3 sequence in ErbAΔBD,
decreased splicing by 40% relative to ErbAΔBD (Fig 3C). To determine
if TR-ISE3 is active in vitro as well as in vivo a parallel series of
transcripts were tested for their ability to undergo splicing when
incubated in vitro with HeLa cell nuclear extract.26, 34 Transcripts
containing sequences corresponding to ΔBD, ΔBE and ΔBP showed a
large increase in splicing when compared to the minigene transcript
α2-ΔBS (Figure 3D). In contrast to their in vivo expression, however,
similar levels of splicing were observed in vitro for all three RNAs, α2ΔBE, α2-ΔBD and α2-ΔBP, suggesting that either only the 3′end of TRISE3 is active in vitro or that the longer introns in α2-ΔBE and α2-ΔBP
counteract the stimulatory effects of the full-length TR-ISE3 enhancer.

Efficient TRα2 mRNA splicing requires exon 10
sequences
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The presence of enhancer elements at either end of the TRα2
intron raises the question whether intronic sequences alone are
sufficient to regulate splicing at the flanking suboptimal 5′ and 3′
splice sites. To assess the possible contribution of sequences within
exon 10 to TRα2 splicing, we constructed a series of deletions within
exon 10. First, 400 nts were deleted from exon 10 of the plasmid
pErbAΔBE starting 31 nt downstream of the 3′ss. This deletion (ΔGM)
removes almost half the length of exon 10, while leaving sequences
adjacent to the splice site and poly(A) sites intact (Figure 4A). When
expressed in HEK 293 cells the transcript ErbAΔGM was very poorly
spliced in comparison with the parent plasmid, pErbAΔBE (Figure 4B).
In fact, the splicing of pErbAΔGM was only slightly greater than that of
pErbAΔBS lacking both TR-ISE3 and SEα2 (Figures 4B, 4C). Next, two
other transcripts each containing 200 nt deletions that represented
either half of the ΔGM deletion were similarly tested. ErbAΔRM, the
transcript with the 3′ deletion, was spliced at almost the same level as
a transcript with the intact exon sequence. In contrast, ErbAΔGR, the
transcript with the 5′ deletion, showed a substantial decrease in
splicing as shown in Figures 4B and 4C. These data suggest the
presence of a splicing enhancer element within the fragment deleted in
ErbAΔGR.

Figure 4

Sequences within exon 10 are required for efficient TRα2 splicing. A.

Diagram of ErbAΔBE minigene transcript showing endpoints of exon 10 deletions. B.
RNase protection assays showing splicing of TRα2 minigene transcripts with exon 10
deletions transfected in HEK 293 cells as described in Fig. 2. C. Quantitation of splicing
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(average of 6 experiments except for ΔBS where n=2). D. RNase protection assays on
transfected minigenes with sequences deleted in ErbAΔGR replaced by homologous
sequence from antisense strand of Rev-erbβ gene (GRβ). E. Quantitation of splicing
(average of 5–8 experiments).

Because a variety of adventitious effects may be associated with
deletions due to the unintended introduction of new sequence
elements or alteration of transcript stability, the activity of the region
encompassed by the ΔGR deletion was examined by two alternate
approaches. First, the GR fragment (deleted in pErbAΔGR) was
replaced in the parental construct with a size-matched sequence (GRβ)
derived from the antisense strand of the homologous Rev-erbβ gene
(NR1D2). Although this fragment is 63% homologous to GR from
TRα2, the Rev-erbβ gene lacks an overlapping antisense mRNA
comparable to TRα2 and thus is also unlikely to have a functional
splicing enhancer on its antisense strand. The resulting construct,
pErbAGRβ, showed low levels of splicing, only 50% that of wildtype, as
shown in Figure 4D and 4E. This result taken together with the
deletion analysis is consistent with the presence of an exonic splicing
enhancer.
To examine the role of exonic sequence elements in enhancing
splicing of TRα2 in vitro, a series of constructs were prepared in which
the sequence deleted in pErbAΔGR was fused to the 3′ end of premRNA derived from exons 3 and 4 from the Drosophila dsx gene but
lacking a functional splicing enhancer.34–36 First, a 200 bp fragment
corresponding to the GR region of exon 10 and the homologous GRβ
antisense sequence from Rev-erbβ were compared for their ability to
promote splicing of the truncated dsx pre-mRNA in HeLa cell nuclear
extract. The transcript with the GR fragment derived from TRα2 (DsxGR) increased splicing of Dsx pre-mRNA to a level much higher than
the parent Dsx minigene transcript, as shown in Figures 5B and 5C. In
contrast, dsx pre-mRNA with the GRβ sequence added was spliced at a
very low level, similar to that of the control Dsx vector transcript (DsxGRβ, Figure 5D). As a positive control, the dsx pre-mRNA with a very
strong ASLV enhancer added35 was tested in parallel and found to
splice at a level similar to that of Dsx-GR (Figures 5C, 5D).
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Figure 5

Sequences within the bidirectional coding region of exon 10 promote

splicing of dsx pre-mRNA. A. Structure of chimeric dsx transcripts. Open boxes
represent exons 3 and 4 of Drosophila dsx pre-mRNA, shaded boxes represent added
sequences from TRα2 exon 10 or ASLV. G100, R100 are 5′ and 3′ half of GR fragment,
respectively. B and C. Splicing of 32P-labeled dsx pre-mRNAs in vitro. Arrows next to
each lane indicate unspliced (U, top) and spliced (S, bottom) RNAs. D. Quantitation of
splicing of dsx pre-mRNAs, average of 3–9 experiments.

To further map sequences required for enhancer activity, the GR
fragment was split into two fragments of 113 nts each, designated
G100 and R100, from the 5′ and 3′ half, respectively, and each
fragment was tested separately. As shown in Figure 5C, fragment
R100 enhanced splicing of dsx pre-mRNA almost to the same level as
the GR fragment. In contrast, the G100 fragment was much less
efficient, as seen by the relatively high ratio of unspliced to spliced
RNA after incubation in HeLa cell nuclear extract. Quantitation of
splicing of Dsx-G100 in multiple splicing assays showed that only
about 20% of this transcript was spliced in contrast to about 60% of
Dsx-R100 (Figs. 5C and 5D). The results shown in Figures 4 and
and5,5, taken together, demonstrate that sequences located within
the 3′ half of the GR fragment constitute an exonic enhancer,
designated ESX10 (exonic splicing enhancer in exon 10).

Multiple sequences within ESX10 enhance splicing
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Since exonic splicing enhancers are often comprised of short
sequence elements, typically 6–9 nt in length, that correspond to
binding sites for individual proteins,37–39 we wished to identify shorter
elements within the R100 fragment. The length of R100 was thus
subdivided into 6 overlapping segments, each of which was 42
nucleotides long (with the exception of fragment“A” that was 43 nts).
These subfragments of R100 were designated R42αA-R42αF as shown
in Figure 6A. The ends of each fragment were staggered 14 nt apart
such that each fragment overlapped the next by 28 nt, to minimize the
chance of truncating active elements. Since the 3′ end of the premRNA affects the stability of the extended dsx pre-mRNA, each
fragment was terminated with the same 5 nt sequence, AGATC, based
on the XbaI runoff site used for transcripts derived from the plasmid
vector, pDsx. Each of the sequences (R42αA-R42αF) was matched with
a homologous sequence derived from the antisense strand of the Reverbβ gene (R42βA-R42βF) to provide a parallel set of six controls.

Figure 6

Mapping of enhancer sequences within R100 fragment. A. R100 fragment

was subdivided into 6 overlapping fragments 42–43 nts in length, R42A R42F, as
shown in diagram. B. and C. Splicing of 32P-labeled chimeric dsx transcripts for 90 min
in vitro with HeLa cell nuclear extract. R42αA to R42αF fragments with positive (Dsx-
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ASLV) and negative (Dsx, vector-only) controls (B) or R42βA to R42βF fragments
using homologous sequences from the antisense strand of Rev-erbβ (C). D.
Quantitation of results in experiments shown in Panels B and C. Light shaded bars:
Dsx-R42α pre-mRNAs; dark shaded bars: Dsx-R42β pre-mRNAs; speckled shading:
controls.

As seen in Figure 6B, each of the 42 (or 43) nt sequences
derived from the TRα2 R100 sequence promoted splicing of dsx premRNA to approximately the same extent. Notably, the strong ASLV
enhancer, which is almost the same length as the 42 nt ESX10
fragments, was only slightly more active than R42αA-R42αF. In
contrast, each of four sequences derived from R100β (R42βC through
R42βF) showed negligible activity (Figures 6C and 6D), while the
remaining two Rev-erbβ antisense fragments, R42βA and R42βB,
showed much lower activity than that associated with the
corresponding R42αA and R42αB fragments from ESX10. To test
whether the 5 nt extension present on all the fragments might
contribute to the observed splicing enhancer activity, R42αF was
prepared with and without the extension. Both fragments were found
to splice with identical efficiency (result not shown). These results
suggest that multiple, functionally redundant enhancer elements are
present within the R100 sequence.
Given the configuration of the overlapping test fragments, as
few as two enhancer elements located within the 14 nt overlaps
between R42αA, R42αB and R42αC and between R42αD, R42αE and
R42αF might account for the consistent enhancement observed with
these fragments, It is more probable, however, that 3 or 4 elements
are dispersed within the R100 region. To further evaluate the role of
such elements a 70 nt region at the 5′ end of R100 was examined.
This region includes the full length of fragments R42αD, R42αE and
R42αF but entirely excludes R42αA. All possible combinations of either
R42αF or R42βF sequence with 28 nts from αD or βD (R28αD′ and
R28βD′) were tested for enhancer activity when fused to dsx premRNA as shown in Figure 7B. The two chimeric 70 nt fragments
displayed intermediate activity relative to the 70 nt sequences from
TRα or the antisense of Rev-erbα (that is R70αFαD′ > R70αFβD′>
R70βFαD′ ≫ R70βFβD′) in proportion to the relative content of TRα
sequence (Figure 7A). These sequences reflect the presence of 28
substitutions (60% identity) within the 70 nt region.
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Figure 7

Enhancer activity of sub-fragments of the exonic splicing enhancer,

ESX10. A. Splicing of dsx pre-mRNA in vitro in HeLa cell nuclear extract showing
enhancement with 70 nt fragments derived from the 5′ end of R100. R42αF or R42βF
was fused to 28 nts from the 3′ end of αD or βD fragment to create R70αFαD′
R70αFβD′, R70βFαD′ and R70βFαD′. B. Schematic representation of transcripts shown
in panels A and C. Open boxes are Dsx exons, light shaded boxes are TRα2 exon 10
sequence, and hatched boxes homologous Rev-erbβ antisense sequences. C. Splicing
of dsx-pre-mRNAs in vitro after 0, 1 and 2 h in which one or two of the three RESCUE
elements (R1, R2 or R3) present in Dsx-R70FD′ (R123) contain the substitutions
shown below. In Panels A and C 0,1,2 h splicing reactions are shown together with
average percent splicing (%) and standard deviation (SD) for four experiments. D.
Sequence of R70αFD′, R70FD′ (R123) and R70βFβD′ fragments. Positions differing in
R70αFD′ and R70βFD′ are marked with asterisks. The sequence of R70βFD′ and
substitutions in R70FD′ (R123) derived from R70βFD′ sequences are shown in
lowercase. Arrows indicate the overlapping sequences R42F, R42E and R42D as well as
the boundary (marked with “/”) between R42F and R28D′. Underlined sequences are
three 7 nt elements, R1, R2 and R3, each comprised of two overlapping ESEassociated hexamers according to the analysis of Fairbrother et al. 40.

To further define the sequences requirements for enhancer
activity, the bioinformatic approach of Fairbrother et al. 38, 40 was
employed to identify three heptamers (R1, R2, R3; underlined in
Figure 7D) comprised of overlapping hexamers with exonic enhancer
activity. Interestingly, one or two of these elements are present in five
of the six R42 fragments. Each of the heptamers is altered by two or
three nucleotide substitutions in the antisense Rev-erbβ sequence
(Figure 7D). When the eight substitutions present in these elements
were introduced together into R70αFD′, splicing of the resulting
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chimera, R70FD(R123), was inhibited more than 95% (Figure 7A). The
effect of these substitutions introduced in R70FD(R123) is greater than
that of a much larger number of substitutions in either R70αFβF or
R70βFαD′, demonstrating that at least two of the elements are
essential for the activity of ESX10. Individual and pairwise introduction
of mutations in R1, R2 and R3 elements into the wildtype R70αFD′
were also analyzed. Individually, the R1 substitution showed the
strongest effect and while R2 and R3 alone each had little effect
(Figure 7C). However, the combination of the mutations in R1 and
either R2 (R70FD′ (R12)) or R3 (R70FD′ (R13)) was very effective in
blocking R70 enhancer activity and the effect on splicing of five
substitutions in R2 and R3 was comparable to that of 11 substitutions
in R70 αFβD′ (Figure 7C). Thus, the enhancer element represented by
R1 acts synergistically with that represented by R2 and R3 to promote
splicing of the heterologous Dsx transcript.

Evolution of ESX 10
To explore the evolution of the overlap, analysis of the region
was extended to non-mammalian vertebrates, which lack TRα2. The
convergent orientation and proximity of the TRα and Rev-erbα genes
in non-mammalian vertebrates is apparent in the frog, Xenopus
tropicalis, where neither the TRα2 coding sequences nor the 3′ ss
specific for TRα2 mRNA are present (not shown). Within the sequence
corresponding to the BCS, the mammalian Rev-erbα amino acid
consensus sequence differs from that of X. tropicalis in only ten of 67
codons (Figure 8A and 8B). Nine of these changes are clustered within
the R100 fragment although it accounts for only a little more than half
the length of the BCS. A total of 19 nucleotide substitutions are
associated with these nine replacements. This pattern of clustered
substitutions maximizes the number of base changes and the range of
amino acid selection relative to the number of amino acid
replacements (Figure 8B). Thus, a small number of largely
conservative amino acid changes in the sequence of Rev-erbα is
sufficient to accommodate both coding and splicing of TRα2.
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Figure 8

Clustering of non-synonymous nucleotide substitutions within ESX10 in a

non-mammalian vertebrate, lacking TRα2. A. Distribution of nucleotides substitutions
within the amphibian sequence homologous to the bidirectional coding sequence of the
mammalian TRα2. The sequencesα from the TRα2 strand of six mammals (Table S1),
and one non-mammalian vertebrate (the frog, Xenopus tropicalis; Joint Genome
Institute Assembly 4.1) were aligned starting with the codon antisense to the stop
codon for Rev-erbα. (boxed) and extend to the Rev-erbα 3′ss (3′ss arrow).
Synonymous substitutions in frog relative to the mammalian consensus are indicated
with an “S”, non-synonymous substitutions with an asterisk. Double-headed arrows
shown positions of G100, R100 and R42F and R28D′ sequences similar to those in
Figure 7D. B. Distribution of amino acid substitutions in final exon of Rev-erbα. The
sequence shown in Panel A is translated for the Rev-erbα antisense strand. Six
mammals are represented: the sequence shown for rat Rev-erbα is identical to that of
mouse, cow and dog; human is identical to chimpanzee. The G100 fragment extends
beyond the sequence shown. C. In vitro splicing for 0,1 and 2 h chimeric Dsx-R70
transcripts derived from the rat TRα2 sequence (αFD′, Fig. 7C) and the homologous
antisense strand of frog Rev-erbα (xFD′) as indicated schematically at right. Light
shading indicates rat sequence, dark shading indicates frog sequences and open boxes
Dsx exons as in Fig. 7B. Percent splicing (%) and standard deviation (SD) are based
on averages of three independent experiments.

Interestingly, both the R1 and R2 elements are perfectly
conserved in X. tropicalis while R3 is altered by a single substitution.
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Comparison of the splicing enhancer activity of amphibian sequences
in the Dsx minigene confirmed that the 70 nucleotide frog sequence,
R70-xFD′, had only 60% activity of the homologous rat R70-αFD′
(Figure 8C). However, the frog antisense sequence displayed
significant activity relative to the ratantisense Rev-erbβ shown in
Figure 7A. For example, activity of the chimeric fragment xFαD′
indicates that the frog xF sequence and the rat αD′ sequences
complement one another to a significant extent (47% splicing of xFαD′
vs. 56% for αFD′; Figure 8C). These results suggest that ancient,
conserved sequences with the 3′ end of Rev-erbα mRNA provided a
foundation for the evolution of an exonic splicing enhancer on the
antisense strand.

Discussion
In this study we have identified two splicing enhancers in the
TRα gene, TR-ISE3, an intronic splicing enhancer, and ESX10, an
exonic splicing enhancer. Both promote use of the alternative 3′ss for
the terminal exon of TRα2 mRNA and map within the antisense overlap
between the 3′ ends TRα2 and Rev-erbα mRNAs. Interestingly, ESX10
maps entirely within a bidirectional coding sequence that includes
sequences coding for both TRα2 and Rev-erbα (Figure 1). Thus the
sequence of this exonic splicing enhancer (ESE) is almost completely
constrained by the in-phase overlap of codons for the two mRNAs. The
C-terminal sequence of Rev-erbα includes part of the heme-binding
pocket which is homologous to the canonical ligand-binding domain
present in other nuclear receptor proteins. The C-terminus of TRα2
confers on this receptor an array of distinctive properties including
site-specific phosphorylation and wide-ranging effects on DNA binding,
heterodimerization and co-repressor interactions.14, 41, 42 The presence
of ESX10 within the Rev-erbα-TRα coding overlap demonstrates the
ability of RNA sequences to encode three layers of information, two
complementary coding sequences and a splicing regulatory element,
within a single sequence.

Identification of TR-ISE3
The TR-ISE3 intronic splicing enhancer was mapped to the 3′
end of the final intron of TRα2 where it appears to act independently of
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SEα2, another previously described intronic splicing enhancer at the 5′
end of the same intron.34 A trivial explanation for these results is that
the activity of TR-ISE3 is based simply on a non-specific increase in
intron length. This possibility can be ruled out for several reasons:
first, the intron in the pErbAΔBS is over 200 nts, much longer than
that required for efficient splicing;43 second, the ErbAΔBS is efficiently
spliced when a single nucleotide substitution is made within either the
5′ or 3′ss (Figure 2B); and third, replacement of the BP fragment of
pErbAΔBP with a size-matched heterologous fragment in ErbA-H
(Figure 3B) of the same length yielded very low splicing, comparable
to that of ErbAΔBS.
The sequence of TR-ISE3 includes most of the G-rich region (Gn,
Figure 1B) and a portion of the highly conserved region just upstream
of the 3′ss polypyrimidine tract. Although the G-rich region (Figures
1C and and3E)3E) is less well conserved than the splice-site proximal
portion of TR-ISE3 (Table S1), similar runs of G residues are present in
many other introns and have been shown to promote alternative and
constitutive splicing.34, 44 Such sequences are often specifically
recognized by hnRNP H/F proteins.34, 45–47 Additionally, G-rich MAZ
elements (consensus sequence G5AG5) affect alternative splicing and
polyadenylation through transcriptional pausing.48–50 Since the G-rich
region in TR-ISE3 is also downstream of the TRα1 poly(A) site, it may
be part of a multifunctional locus that impacts transcription as well as
processing.

Characterization of ESX10
Results presented here demonstrate that the coding sequence of
TRα2 overlapping that of Rev-erbα includes ESX10, an exonic splicing
enhancer (ESE) located140–250 nt downstream of the 3′ ss. This
region accounts for a substantial portion of the splicing activity that is
abolished by the deletion of the splice site proximal portion of the exon
in ErbAΔGR (Figure 4). RESCUE analysis38, 40 revealed a provocative
distribution of three enhancer-related heptanucleotide sequences (R1,
R2 and R3) across a 70 nucleotide region within R100 (Figure 7D).
Substitution of three nucleotides in R1 alone results in a loss of almost
75 % of splicing activity. While substitutions within R2 and R3
individually result in only modest decrease in splicing, the combination
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of five substitutions within these two closely spaced heptamers
decreases splicing activity by about 40% suggesting that R2 and R3
together constitute a single functional subelement, R2/R3, of the
ESX10 enhancer. Substitutions within all three elements decrease
splicing activity by >95% (Figure 7A). These results suggest a
hierarchy of interacting enhancer elements within the R100 fragment
that act synergistically to promote TRα2 splicing. The non-overlapping
fragment R42αA is also active in heterologous splicing assays (Fig. 6).
Thus ESX10 is a complex ESE comprised of at least three active
subelements mapping to sites at R1, R2/R3 and R42A.
Another bioinformatic approach for identifying exonic splicing
enhancers involves analysis of consensus binding sites for SR proteins,
often associated with ESEs, as implement in the program ESEfinder.37,
39, 51
ESEfinder revealed a large number of candidate binding sites for
SR proteins SF2/ASF, SC35, SRp55 and SRp75 within the R100 region
of ESX10 (results not shown) with SC35, SRp 40 and SF2/ASF (SFRS1)
associated with sites R1, R2 and R3, respectively. In contrast, far
fewer sites are present within the homologous region of the antisense
Rev-erbβ strand. However, substitutions in R1 that reduced splicing
activity had little effect on the ESEfinder score for SC35 binding at this
site. Thus further biochemical studies are required to determine the
array of proteins and other factors interacting with ESX10.

Co-evolution of TRα2 splicing and ESX 10
Most ESEs map within coding exons of mRNAs52, 53 where the
dual constraints introduced by requirements for coding and splicing are
discernible in the statistical bias of synonymous mutations near the
ends of exons adjacent to splice sites.7, 31, 54, 55 The location of ESX10
within the coding sequences for both TRα2 and Rev-erbα shows that
this region simultaneously accommodates at least three layers of
specific information and illustrates the surprising capacity of the
genetic code to accommodate additional information as recently
described by Itzkovitz and Alon.56, 57 The high level of sequence
conservation and the presence of numerous functional constraints
make it possible to map the evolutionary history of this locus in detail
to reconstruct the evolutionary process by which information required
for TRα2 splicing and coding has been superimposed on Rev-erbα
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coding sequence. Although Rev-erbα but not TRα is present in model
organisms such as flies and nematodes, detailed phylogenetic analysis
indicate that homologs of both nuclear receptor proteins were present
in the urbilaterian ancestor more than 540 MYA.58, 59 In addition, the
convergent orientation of TRα and Rev-erbα is conserved among many
non-mammalian vertebrates (e.g. fish and amphibians), which lack
TRα2, as well as in the more distantly related and non-overlapping TRβ
and Rev-erbβ genes. These observations strongly suggest that the
proximity and orientation of these genes have ancient functions
independent of TRα2 expression.
In the genome of the frog X. tropicalis coding sequences of
TRα1 and Rev-erbα are situated 15 kb apart (vs. only 3.6 kb in
mammals) and no sequences corresponding to TRα2 are present,
consistent with TRα2 being a recent evolutionary innovation specific to
mammals.33 Since the C-termini of Rev-erbα and Rev-erbβ are tightly
conserved in vertebrates, only a limited number of changes are
associated with the appearance of TRα2 in the mammalian lineage.
Within the R100 fragment the frequency of non-synonymous
substitution is 10-fold higher (0.17 substitutions/nt) than in the rest of
the BCS, while the occurrence of synonymous substitutions is
relatively constant throughout. The clustering of non-synonymous
substitutions in R100 maximizes the number of base changes for a
given number of amino acid replacements. These changes are
sufficient to overlay information for splicing enhancement on the
coding sequences for both Rev-erbα and TRα2. The evolution of TRα2
is likely to have been facilitated by the presence of such sequences
compatible with ESX10 activity as evident in the conservation of both
R1 and R2 on the antisense strand of Rev-erbα in X. tropicalis (Fig.
8A) but not that of the more distantly related Rev-erbβ (Fig. 7D).
Consistent with this hypothesis, the X. tropicalis R1 sequence is able to
activate splicing of a Dsx chimera that includes R2 and R3 from rat
(compare αFD′ and xFαD′ in Figure 8C). This analysis suggests that
initial steps in the evolution of TRα2 may require only the evolution of
a marginally efficient 3′ss sequence on the antisense strand of the
Rev-erbα 3′ UTR. This scenario is consistent with general requirements
for the evolution of alternatively spliced exons in many other genes.32,
60
According to this model, the amino acid sequence of TRα2 and an
increasingly efficient splicing enhancer (ESX10) may then have
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coevolved after establishment of an inefficiently spliced TRα2 terminal
exon, antisense to Rev-erbα.

Role of antisense overlap in regulating TRα expression
Antisense transcription is widespread in mammalian genomes4,
12, 13, 42, 61–63
The convergent overlap orientation observed for TRα2 and
Rev-erbα mRNAs is the most frequently observed arrangement for
overlapping mRNAs12, 62 although a coding-coding overlap is less
common, representing only 10% of overlapping genes.64 Several lines
of evidence support a role for Rev-erbα expression in repressing TRα2
splicing: antisense RNA from the 3′ end of Rev-erbα efficiently blocks
splicing in vitro, and increase in Rev-erbα mRNA expression is
associated with a decrease in the expression of TRα2 mRNA relative to
TRα1 in vivo in various cells types.25–28
The presence of multiple splicing enhancer elements within the
overlap region (Figure 1) suggests several specific possible
mechanisms for antisense regulation. For example, base-pairing within
Rev-erbα and TRα2 mRNA may block binding of splicing factors as
suggested by previous in vitro experiments26 and the proximity of TRISE3 the 3′ end of the complementary Rev-erbα mRNA may be
important for initiating base-pairing as shown in prokaryotes.65
However, mechanisms associated with antisense RNA are very diverse,
involving both transcriptional and post-transcriptional regulation and
including positive as well as negative effects on target expression.5, 66–
68

Since both TRα and Rev-erbα regulate many aspects of
mammalian development and physiology, it is not surprising that their
expression and function is regulated at many levels.42, 69- 71 Over the
past several decades it has become evident that gene expression is
regulated by many different processes that are often closely linked.4, 72,
73
The evolution of regulatory elements within regions containing
multiple layers of genetic information, as demonstrated here for
ESX10, may prove a common theme as our ability to interpret the
complex information encoded within the mammalian genome
continues to advance.
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Materials and Methods
Plasmid constructs
Construction of pErbA, pErbAΔBS and pErbAΔXS has been
previously described.28 pErbAΔBS(5′ss+5G) was constructed by
swapping the 5′ portion of pCMV-erbAm(5′ss+5G) with wildtype
sequence of pErbAΔBS. pErbAΔBS(3′ss-3A) was constructed using PCR
to replace a single nucleotide at the 3′ ss as shown in Figure 2A.
pErbAΔBD and pErbAΔBP are similar to pErbAΔBS except for the
addition of fragments defined by Dra I and Pvu II sites, 81 and 160 bp,
respectively, upstream of the SspI site that marks the 3′ end of the
ΔBS deletion. pErbAΔBE includes a similar fragment 118 bp in length
that was constructed via PCR with an upstream end halfway between
the sites defining pErbAΔBD and pErbAΔBP. ErbAΔXS, pErbAΔXD,
pErbAΔXE and pErbΔXP include deletions identical to those in
pErbAΔBS through pErbAΔBP except that each includes a 250 bp
Bsu36I/XbaI fragment at the 5′ end of the deletion marked by the
Bsu36I site. Deletions were constructed in exon 10 of pErbAΔBE as
follows: pErbAΔGM was created by digesting pErbAΔBE with BsrGI and
PflMI, Klenow endfilling and ligating; pErbAΔGR was made from
pErbAΔBE by introducing a deletion between the unique BsrGI site and
the EcoRI site in exon 10; finally, pErbAΔRM was constructed in a
similar way by deleting sequences between the same EcoRI site and a
PflMI site 220 bp downstream in exon 10. The replacement of the
BsrGI-EcoRI fragment with the corresponding antisense Rev-erbβ
fragment was achieved by cloning a cDNA copy of the human Rev-erbβ
gene into these sites in pErbAΔBE.
pDsx constructs were created from pDsx/KX as previously
described.34, 35, 74 pDsxGR has a 200 nt PCR fragment copied from the
BsrGI/EcorI fragment in exon 10 of TRα2 inserted between the KpnI
and Xba I site of pDsx/KX. This fragment was created with pErbA as a
template using a reverse primer that included EcoRI and XbaI sites
matching those in the vector at its 5′ end and a forward primer with
BsrGI and KpnI sites at its 5′ end. The PCR fragment and Dsx vector
were cut with KpnI and XbaI and ligated. pDsxR100 was created using
the EcoRI/XbaI primer described above and a second primer with a
KpnI site adjacent to the site at the center of the GR fragment.
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pDsxG100 was created in a similar manner, using the forward primer
with BsrGI and KpnI sites added and a reverse primer with XbaI site
complement to sequences adjacent to the start of R100. Dsx
constructs containing extensions shorter than those associated with
R100 or G100 were prepared as PCR products using pDsx-derived
plasmids as templates with a forward primer upstream of the T7
promoter and a reverse primer with the desired wildtype or mutant
sequences as shown in Table S2. All plasmids generated by PCR were
sequenced. Further information on the sequence of all plasmids is
available on request.

Plasmid transfection, transcription and in vitro splicing
pErbA plasmids were transfected into HEK 293 cells via calcium
phosphate-mediated transfection as described.27 32P-labeled RNA
transcripts were synthesized from either linearized plasmids or PCR
templates containing a bacteriophage promoter as previously
described.34, 75 Templates for the pDsx/KX-ESX10 transcripts were
linearized with XbaI, pDsx-ASLV was linearized with MluI and pDsx
with BamHI. In vitro splicing was carried out as previously
described.26, 34, 36 To start each reaction HeLa cell nuclear extract was
added to a solution containing the 32P-UTP labeled transcripts. The
reaction was stopped at the times indicated and the products were run
on a 5.5% polyacrylamide gel.
To determine the ratio of TRα1/TRα2 mRNA, a 32P-labeled probe
that overlaps the TRα2 5′ splice site was used in the RNase protection
assay as described.27, 34 The probe covers 162 nt at the 3′ most
portion of TRα1 or 135 nt complementary to exon 9A of TRα2 mRNA.
Following electrophoresis, gels were scanned with an Ambis
radioanalytic scanner or Storm phosphoimager. Counts from each
band were corrected for uridine content in calculating the percent
splicing.26, 34

Supplementary Material
S1 Table S1: Conservation of the overlap between TRα2 and Rev-erbα
mRNAs. Crosstables for pairwise comparison regions of overlap shown in
Figure 1. Lengths of regions refer to the genomic sequence of the rat
(NW_047339) and vary slightly between genomes. Two crosstables are shown
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for the 3′ end of TRα1 mRNA (TRα1 3′UTR in Fig. 1C) since the chimpanzee
sequence (NW_001226923) includes only the final 116 bp. The bidirectional
coding sequence is 200 bp within the exon-exon overlap, while intron 7 of
Rev-erbα mRNA overlaps with 46 bp of TRα2 coding sequence and 470 bp of
the TRα2 3′ UTR. Other sequences in the alignment are NT_010755 (human),
NT_165773 (mouse), NW_876332 (dog) and NW_001493677 11. Positions of
the TRα1, TRα2 and Rev-erbα poly(A) sites are based on RNase protection
mapping and cDNA sequences.19, 28
Table S1: Identity within the region of overlap between TRα2 and Rev-erbα mRNAs
3'end TRa1(205 BP)
COW
DOG
RAT
MOUSE

DOG
96

RAT
96
96

MOUSE
96
96
99

HUMAN
97
98
98
98

DOG
100

RAT
100
100

MOUSE
100
100
100

HUMAN
100
100
100
100

CHIMP
100
100
100
100
100

DOG
96

RAT
89
90

MOUSE
87
89
96

HUMAN
93
97
94
92

CHIMP
94
96
93
91
100

DOG
97

RAT
91
94

MOUSE
94
97
97

HUMAN
96
98
96
98

CHIMP
96
98
96
98
100

DOG
85

RAT
73
80

MOUSE
74
80

HUMAN
76
80

CHIMP
78
80

3' end of TRa1 ( 116 bp including Chimp)
COW
DOG
RAT
MOUSE
HUMAN
C-rich (140 BP)
COW
DOG
RAT
MOUSE
HUMAN
Rev-erba poly(A) proximal region (70 BP)
COW
DOG
RAT
MOUSE
HUMAN
G-rich Region (78 BP)
COW
DOG
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RAT
MOUSE
HUMAN

96

77
76

77
76
99

RAT
99
98

MOUSE
99
98
100

HUMAN
99
98
100
100

CHIMP
99
98
100
100
100

RAT
99
99

MOUSE
99
99
100

HUMAN
98
99
99
99

CHIMP
98
99
99
99
100

DOG
86

RAT
83
83

MOUSE
81
83
94

HUMAN
86
90
85
84

CHIMP
86
90
86
85
99

DOG
95

RAT
93
90

MOUSE
95
93
94

HUMAN
96
94
93
95

CHIMP
96
94
93
95
100

Conserved region upstream of TRa2 3'ss
(99 BP)
COW
DOG
RAT
MOUSE
HUMAN

DOG
99

Exon-Exon Overlap of TRa2 and Rev-erba mRNA
(163 BP)
DOG
COW
98
DOG
RAT
MOUSE
HUMAN
Intron 7 of Rev-erba mRNA (620 BP)
COW
DOG
RAT
MOUSE
HUMAN
Exon 7 of Rev-erba (211 bp)
COW
DOG
RAT
MOUSE
HUMAN

S2 Table S2: Primers used for construction of plasmids and transcription
templates. Forward (F) and reverse (R) orientations of the primers are
indicated. The primers for the Dsx-R42 templates include an overlap with the
exon 4 of dsx mRNA at their 3′ end. The reverse primers for R100 and R42A
Dsx constructs include at their 5′ end an EcoRI site that is not conserved in
Rev-erbα.
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Table S2: Primers used for plasmids constructions.
Description of
plasmid construct
pErbADXE
pErbADXE
pErbADBS(3'ss3C)
pErbADBS(3'ss3C)
pDsx (upstream
primer)
pDsx/KX-R100
pDsx/KX-G100
pDsx/KX-GR and
pDsx/KX-R100
pDsx/KX-GR and
pDsx/KX-G100

Direction
F
R

Sequence (5' to 3')
AGCTCTAGAGGGGCCAGAGGAGGGTG
CATGGACGTAGTGGCCGGACT

F
R

GCTTTTCCTTTCGTCTCGTACAGGAG
ACGAAAAGGAAAAGCAAAGGAAAAGGTTAGTAATATTG
TTATAA

F
F
R

CGGCCAGTGAATTGTAATACG
CGGGTACCGCTTGAGCAGCAGTTTGGTG
GGCTCTAGATGCCGGACCTGCGGACCCTG

R

GGCTCTAGAGAATTCCGCTTCGGTGGAGC

F

CGGGTACCTGTACAAGGGGGCAGCGGCAG
CTAGA GAA TTCCGCTTCG GTGGAGCAGC
TCCAGGAGAC GCTGCTGCGG
TACCGCGATCCAAGCTTATC
CTAGA GGAGCAGC TCCAGGAGAC GCTGCTGCGG
GCTCTTCGGG CTCT TACCGCGATCCAAGCTTATC
CTAGA AGAC GCTGCTGCGG GCTCTTCGGG
CTCTGGTGCT GAAGAACC
TACCGCGATCCAAGCTTATC
CTAGA GCTCTTCGGG CTCTGGTGCT GAAGAACCGG
CCCTCGGAGA CT TACCGCGATCCAAGCTTATC
CTAGA GGTGCT GAAGAACCGG CCCTCGGAGA
CTTCCCGCTT CACCAA TACCGCGATCCAAGCTTATC
CTAGA GG CCCTCGGAGA CTTCCCGCTT
CACCAAACTG CTGCTCAAGC
TACCGCGATCCAAGCTTATC
CTAGA GAA TTC CAACTCT GTGGAGGCTT
TGCAGGAAAC TCTCATTCGT
TACCGCGATCCAAGCTTAT
CTAGA GGAGCAGC TCCAGGAGAC GCTGCTGCGG
GCTCTTCGGG CTCT TACCGCGATCCAAGCTTATC
CTAGA AAAC TCTCATTCGT GCACTAAGGA
CCTTAATAAT GAAAAACC TACCGCGATCCAAGCTTATC
CTAGA GCACTAAGGA CCTTAATAAT GAAAAACCAT
CCAAATGAGG CC TACCGCGATCCAAGCTTATC
CTAGA AATAAT GAAAAACCAT CCAAATGAGG
CCTCTATTTT TACAAA TACCGCGATCCAAGCTTATC
CTAGA AT CCAAATGAGG CCTCTATTTT TACAAAACTG
CTTCTAAAGT TACCGCGATCCAAGCTTATC
CTAGAGCTCTTCGGGCTCTGGTGCTG

Dsx/KX-R42aA

R

Dsx/KX-R42aB

R

Dsx/KX-R42aC

R

Dsx/KX-R42aD

R

Dsx/KX-R42aE

R

Dsx/KX-R42aF

R

Dsx/KX-R42bA

R

Dsx/KX-R42bB

R

Dsx/KX-R42bC

R

Dsx/KX-R42bD

R

Dsx/KX-R42bE

R

Dsx/KX-R42bF
Dsx/KX-R70aFD'

R
R
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Dsx/KX-R70aFbD'

R

Dsx/KX-R70bFaD'
Dsx/KX-R70bFD'
Dsx/KXR42aFD5(3'XbaI)
Dsx/KXR42aFD12(3')
Dsx/KXR42aFD12(5')
Dsx/KXR70aFD'(R123)
Dsx/KXR70aFD'(R12)
Dsx/KXR70aFD'(R13)
Dsx/KXR70aFD'(R23)

R
R

R70 aFD(R1)

R

R70 aFD(R2)
R70 aFD(R3)

R
R

R70xFD'

R

R70xFaD'

R

R70aFxD'

R

R
R
R
R
R
R
R

CTAGA GCA CTA AGG ACC TTA ATA ATG AAA AAC
CGG CCC TCG GAG ACT TCC CG
CTAGA GCT CTT CGG GCT CTG GTG CTG AAG AAC
CAT CCA AAT GAG GCC TCT AT
CTAGA GCA CTA AGG ACC TTA ATA ATG
GGCCCTCGGAGACTTCCCGCTTCACCAAACTGCTGCTC
AAGCTACCGCGATCCAAGCTTATC
CTAGACCTTCCCGCTTCACCAAACTGCTGCTCAAGCTAC
CGCGATCCAAGCTTATC
CTAGAGGCCCTCGGAGACTTCCCGCTTCACCAAACTAC
CGCGATCCAAGCTTATC
CTA GA GCAC TAA GGG CTC TGG TGA TGA AAA ACC
GGC CCT CGG AGA CTT CCC t
CTAGA GCTCTTC GGGCTCT GGTGaTG AAaAACC
GGCCCTC GGAGACT TCCCt
CTAGA GCACTAA GGGCTC TGG TGC TGA AGA ACC
GGC CCT CGG AGA CTT CCC t
CTAGA GCaCTaa GGGCTCT GGTGaTG AAaAACC
GGCCCTC GGAGACT TC
CTAGA
GCTCTTCGGGCTCTGGTGCTGAAGAACCGGCCCTCGA
GACTTCCC T
CTAGA GCTCTTC GGGCTCT GGTGaTG AAaAACC
GGCCCTC GGAGACT TC
CTA GAG CAC TAA GGG CTC TGG TGC TGA AGA AC
CTAGA GCc CTT CGtt CcC T ca TcC TGA AGA Aca Gt
Cca aac Gat A Cc TCC CGC
CTAGA GC TCT TCG GGC TCT GG TGC TGA AGA ACC
Gt Cca aac GAt ACc TCC CGC
CTAGA GC cCT TCG ttCcC T ca TcC TGA AGA Aca GG
CCC TC GGA GAC TTC CCGCT
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3′ss 3′ splice site
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nt nucleotides
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BCS bi-directional coding sequence
ESE exonic splicing enhancer
ISE intronic splicing enhancer

References
1. Black DL. Mechanisms of alternative pre-messenger RNA splicing.
Annu Rev Biochem. 2003;72:291–336.
2. Munroe SH. Diversity of antisense regulation in eukaryotes: multiple
mechanisms, emerging patterns. J Cell Biochem. 2004;93:664–
71.
3. Lavorgna G, Dahary D, Lehner B, Sorek R, Sanderson CM, Casari G.
In search of antisense. Trends Biochem Sci. 2004;29:88–94.
4. Kapranov P, Willingham AT, Gingeras TR. Genome-wide
transcription and the implications for genomic organization. Nat
Rev Genet. 2007;8:413–23.
5. Munroe SH, Zhu J. Overlapping transcripts, double-stranded RNA
and antisense regulation: a genomic perspective. Cell Mol Life
Sci. 2006;63:2102–18.
6. Hastings ML, Krainer AR. Pre-mRNA splicing in the new millennium.
Curr Opin Cell Biol. 2001;13:302–9.
7. Matlin AJ, Clark F, Smith CW. Understanding alternative splicing:
towards a cellular code. Nat Rev Mol Cell Biol. 2005;6:386–98.
8. Gustincich S, Sandelin A, Plessy C, Katayama S, Simone R,
Lazarevic D, et al. The complexity of the mammalian
transcriptome. J Physiol. 2006;575:321–32.
9. Modrek B, Lee C. A genomic view of alternative splicing. Nat Genet.
2002;30:13–9.
10. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et
al. Alternative isoform regulation in human tissue
transcriptomes. Nature. 2008;456:470–6.
11. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of
alternative splicing complexity in the human transcriptome by
high-throughput sequencing. Nat Genet. 2008;40:1413–5.
12. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M,
Nakamura M, et al. Antisense transcription in the mammalian
transcriptome. Science. 2005;309:1564–6.
13. He Y, Vogelstein B, Velculescu VE, Papadopoulos N, Kinzler KW.
The antisense transcriptomes of human cells. Science.
2008;322:1855–7.
RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

29

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

14. Lazar MA. Thyroid hormone receptors: multiple forms, multiple
possibilities. Endocr Rev. 1993;14:184–93.
15. Committee on Nuclear Receptor Nomenclature. A unified
nomenclature system for the nuclear receptor superfamily. Cell.
1999;97:161–3.
16. Tagami T, Kopp P, Johnson W, Arseven OK, Jameson JL. The
thyroid hormone receptor variant alpha2 is a weak antagonist
because it is deficient in interactions with nuclear receptor
corepressors. Endocrinology. 1998;139:2535–44.
17. Strait KA, Schwartz HL, Perez-Castillo A, Oppenheimer JH.
Relationship of c-erbA mRNA content to tissue triiodothyronine
nuclear binding capacity and function in developing and adult
rats. J Biol Chem. 1990;265:10514–21.
18. Keijzer R, Blommaart PJ, Labruyere WT, Vermeulen JL, Doulabi BZ,
Bakker O, et al. Expression of thyroid hormone receptors A and
B in developing rat tissues; evidence for extensive
posttranscriptional regulation. J Mol Endocrinol. 2007;38:523–
35.
19. Lazar MA, Hodin RA, Darling DS, Chin WW. A novel member of the
thyroid/steroid hormone receptor family is encoded by the
opposite strand of the rat c-erbA alpha transcriptional unit. Mol
Cell Biol. 1989;9:1128–36.
20. Miyajima N, Horiuchi R, Shibuya Y, Fukushige S, Matsubara K,
Toyoshima K, et al. Two erbA homologs encoding proteins with
different T3 binding capacities are transcribed from opposite
DNA strands of the same genetic locus. Cell. 1989;57:31–9.
21. Yin L, Wu N, Curtin JC, Qatanani M, Szwergold NR, Reid RA, et al.
Rev-erbalpha, a heme sensor that coordinates metabolic and
circadian pathways. Science. 2007;318:1786–9.
22. Raghuram S, Stayrook KR, Huang P, Rogers PM, Nosie AK, McClure
DB, et al. Identification of heme as the ligand for the orphan
nuclear receptors REV-ERBalpha and REV-ERBbeta. Nat Struct
Mol Biol. 2007;14:1207–13.
23. Preitner N, Damiola F, Lopez-Molina L, Zakany J, Duboule D,
Albrecht U, et al. The orphan nuclear receptor REV-ERBalpha
controls circadian transcription within the positive limb of the
mammalian circadian oscillator. Cell. 2002;110:251–60.

RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

30

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

24. Pardee KI, Xu X, Reinking J, Schuetz A, Dong A, Liu S, et al. The
structural basis of gas-responsive transcription by the human
nuclear hormone receptor REV-ERBbeta. PLoS Biol. 2009;7:e43.
25. Lazar MA, Hodin RA, Cardona G, Chin WW. Gene expression from
the c-erbA alpha/Rev-ErbA alpha genomic locus. Potential
regulation of alternative splicing by opposite strand
transcription. J Biol Chem. 1990;265:12859–63.
26. Munroe SH, Lazar MA. Inhibition of c-erbA mRNA splicing by a
naturally occurring antisense RNA. J Biol Chem.
1991;266:22083–6.
27. Hastings ML, Milcarek C, Martincic K, Peterson ML, Munroe SH.
Expression of the thyroid hormone receptor gene, erbAalpha, in
B lymphocytes: alternative mRNA processing is independent of
differentiation but correlates with antisense RNA levels. Nucleic
Acids Res. 1997;25:4296–300.
28. Hastings ML, Ingle HA, Lazar MA, Munroe SH. Post-transcriptional
regulation of thyroid hormone receptor expression by cis-acting
sequences and a naturally occurring antisense RNA. J Biol
Chem. 2000;275:11507–13.
29. Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutral
evolution at synonymous sites in mammals. Nat Rev Genet.
2006;7:98–108.
30. Warnecke T, Parmley JL, Hurst LD. Finding exonic islands in a sea
of non-coding sequence: splicing related constraints on protein
composition and evolution are common in intron-rich genomes.
Genome Biol. 2008;9:R29.
31. Willie E, Majewski J. Evidence for codon bias selection at the premRNA level in eukaryotes. Trends Genet. 2004;20:534–8.
32. Xing Y, Lee C. Alternative splicing and RNA selection pressure-evolutionary consequences for eukaryotic genomes. Nat Rev
Genet. 2006;7:499–509.
33. Forrest D, Sjoberg M, Vennstrom B. Contrasting developmental
and tissue-specific expression of alpha and beta thyroid
hormone receptor genes. EMBO J. 1990;9:1519–28.
34. Hastings ML, Wilson CM, Munroe SH. A purine-rich intronic element
enhances alternative splicing of thyroid hormone receptor
mRNA. RNA. 2001;7:859–74.

RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

31

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

35. Tanaka K, Watakabe A, Shimura Y. Polypurine sequences within a
downstream exon function as a splicing enhancer. Mol Cell Biol.
1994;14:1347–54.
36. Tian M, Maniatis T. A splicing enhancer complex controls
alternative splicing of doublesex pre-mRNA. Cell. 1993;74:105–
14.
37. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A
web resource to identify exonic splicing enhancers. Nucleic Acids
Res. 2003;31:3568–71.
38. Fairbrother WG, Yeh RF, Sharp PA, Burge CB. Predictive
identification of exonic splicing enhancers in human genes.
Science. 2002;297:1007–13.
39. Liu HX, Zhang M, Krainer AR. Identification of functional exonic
splicing enhancer motifs recognized by individual SR proteins.
Genes Dev. 1998;12:1998–2012.
40. Fairbrother WG, Yeo GW, Yeh R, Goldstein P, Mawson M, Sharp PA,
et al. RESCUE-ESE identifies candidate exonic splicing enhancers
in vertebrate exons. Nucleic Acids Res. 2004;32:W187–90.
41. Katz D, Lazar MA. Dominant negative activity of an endogenous
thyroid hormone receptor variant (alpha 2) is due to competition
for binding sites on target genes. J Biol Chem.
1993;268:20904–10.
42. Engstrom PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna
G, et al. Complex Loci in human and mouse genomes. PLoS
Genet. 2006;2:e47.
43. Green MR. Pre-mRNA splicing. Annu Rev Genet. 1986;20:671–
708.
44. McCullough AJ, Berget SM. G triplets located throughout a class of
small vertebrate introns enforce intron borders and regulate
splice site selection. Mol Cell Biol. 1997;17:4562–71.
45. Caputi M, Zahler AM. Determination of the RNA binding specificity
of the heter ogeneous nuclear ribonucleoprotein (hnRNP)
H/H′/F/2H9 family. J Biol Chem. 2001;276:43850–9.
46. Han K, Yeo G, An P, Burge CB, Grabowski PJ. A combinatorial code
for splicing silencing: UAGG and GGGG motifs. PLoS Biol.
2005;3:e158.
47. Martinez-Contreras R, Fisette JF, Nasim FU, Madden R, Cordeau M,
Chabot B. Intronic binding sites for hnRNP A/B and hnRNP F/H
proteins stimulate pre-mRNA splicing. PLoS Biol. 2006;4:e21.

RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

32

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

48. Ashfield R, Patel AJ, Bossone SA, Brown H, Campbell RD, Marcu
KB, et al. MAZ-dependent termination between closely spaced
human complement genes. EMBO J. 1994;13:5656–67.
49. Robson-Dixon ND, Garcia-Blanco MA. MAZ elements alter
transcription elongation and silencing of the fibroblast growth
factor receptor 2 exon IIIb. J Biol Chem. 2004;279:29075–84.
50. Roberts GC, Gooding C, Mak HY, Proudfoot NJ, Smith CW. Cotranscriptional commitment to alternative splice site selection.
Nucleic Acids Res. 1998;26:5568–72.
51. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. An
increased specificity score matrix for the prediction of SF2/ASFspecific exonic splicing enhancers. Hum Mol Genet.
2006;15:2490–508.
52. Mayeda A, Screaton GR, Chandler SD, Fu XD, Krainer AR.
Substrate specificities of SR proteins in constitutive splicing are
determined by their RNA recognition motifs and composite premRNA exonic elements. Mol Cell Biol. 1999;19:1853–63.
53. Schaal TD, Maniatis T. Multiple distinct splicing enhancers in the
protein-coding sequences of a constitutively spliced pre-mRNA.
Mol Cell Biol. 1999;19:261–73.
54. Cartegni L, Chew SL, Krainer AR. Listening to silence and
understanding nonsense: exonic mutations that affect splicing.
Nat Rev Genet. 2002;3:285–98.
55. Parmley JL, Chamary JV, Hurst LD. Evidence for purifying selection
against synonymous mutations in mammalian exonic splicing
enhancers. Mol Biol Evol. 2006;23:301–9.
56. Itzkovitz S, Alon U. The genetic code is nearly optimal for allowing
additional information within protein-coding sequences. Genome
Res. 2007;17:405–12.
57. Bollenbach T, Vetsigian K, Kishony R. Evolution and multilevel
optimization of the genetic code. Genome Res. 2007;17:401–4.
58. Escriva H, Bertrand S, Laudet V. The evolution of the nuclear
receptor superfamily. Essays Biochem. 2004;40:11–26.
59. Segraves WA, Hogness DS. The E75 ecdysone-inducible gene
responsible for the 75B early puff in Drosophila encodes two
new members of the steroid receptor superfamily. Genes Dev.
1990;4:204–19.

RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

33

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

60. Xiao X, Wang Z, Jang M, Burge CB. Coevolutionary networks of
splicing cis-regulatory elements. Proc Natl Acad Sci U S A.
2007;104:18583–8.
61. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa
D, et al. Unbiased mapping of transcription factor binding sites
along human chromosomes 21 and 22 points to widespread
regulation of noncoding RNAs. Cell. 2004;116:499–509.
62. Chen J, Sun M, Kent WJ, Huang X, Xie H, Wang W, et al. Over
20% of human transcripts might form sense-antisense pairs.
Nucleic Acids Res. 2004;32:4812–20.
63. Kiyosawa H, Mise N, Iwase S, Hayashizaki Y, Abe K. Disclosing
hidden transcripts: mouse natural sense-antisense transcripts
tend to be poly(A) negative and nuclear localized. Genome Res.
2005;15:463–74.
64. Veeramachaneni V, Makalowski W, Galdzicki M, Sood R,
Makalowska I. Mammalian overlapping genes: the comparative
perspective. Genome Res. 2004;14:280–6.
65. Nordstrom K, Wagner EG. Kinetic aspects of control of plasmid
replication by antisense RNA. Trends Biochem Sci.
1994;19:294–300.
66. Shearwin KE, Callen BP, Egan JB. Transcriptional interference--a
crash course. Trends Genet. 2005;21:339–45.
67. Beiter T, Reich E, Williams RW, Simon P. Antisense transcription: a
critical look in both directions. Cell Mol Life Sci. 2009;66:94–
112.
68. Mahmoudi S, Henriksson S, Corcoran M, Mendez-Vidal C, Wiman
KG, Farnebo M. Wrap53, a natural p53 antisense transcript
required for p53 induction upon DNA damage. Mol Cell.
2009;33:462–71.
69. Bookout AL, Jeong Y, Downes M, Yu RT, Evans RM, Mangelsdorf
DJ. Anatomical profiling of nuclear receptor expression reveals a
hierarchical transcriptional network. Cell. 2006;126:789–99.
70. Burris TP. Nuclear hormone receptors for heme: REV-ERBalpha
and REV-ERBbeta are ligand-regulated components of the
mammalian clock. Mol Endocrinol. 2008;22:1509–20.
71. Flamant F, Samarut J. Thyroid hormone receptors: lessons from
knockout and knock-in mutant mice. Trends Endocrinol Metab.
2003;14:85–90.

RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

34

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

72. Darnell JE., Jr Variety in the level of gene control in eukaryotic
cells. Nature. 1982;297:365–71.
73. Bartel DP, Chen CZ. Micromanagers of gene expression: the
potentially widespread influence of metazoan microRNAs. Nat
Rev Genet. 2004;5:396–400.
74. McNally LM, McNally MT. An RNA splicing enhancer-like sequence is
a component of a splicing inhibitor element from Rous sarcoma
virus. Mol Cell Biol. 1998;18:3103–11.
75. Munroe SH. Antisense RNA inhibits splicing of pre-mRNA in vitro.
EMBO J. 1988;7:2523–32.

About the Authors:
Address correspondence to: Stephen H. Munroe, Department of Biological
Sciences, Wehr Life Sciences Building 109, Marquette University, PO Box
1881, Milwaukee, WI 53201, Tel: 414-288-1485, FAX: 414-288-7357, Email:
munores@marquette.edu
Valerie K. Salato: Current address: Department of Pathology, Medical College
of Wisconsin, Milwaukee, WI 53226.
Nathaniel W. Rediske: Current address: School of Medicine, Oregon Health
and Science University, Portland, OR 97239.
Michelle L. Hastings: Current address: Department of Cell Biology and
Anatomy, Chicago Medical School, Rosalind Franklin University of Medicine
and Science, North Chicago, IL 60064

RNA Biology, Vol. 7, No. 2 (March 2010): pg. 179-190. DOI. This article is © Taylor & Francis and permission has been
granted for this version to appear in e-Publications@Marquette. Taylor & Francis does not grant permission for this
article to be further copied/distributed or hosted elsewhere without the express permission from Taylor & Francis.

35

